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Objective: To examine the role of the balance between interleukin (IL)-1 and IL-1 receptor antagonist (IL-1Ra) in atherosclerosis and
vascular inflammation.
Methods: Transgenic (Tg) mice overexpressing either secreted IL-1Ra or intracellular IL-1Ra1 as well as IL-1Ra-deficient mice (IL-1Ra
/) were crossed with apolipoprotein E-deficient mice (ApoE /).
Results: In males fed a cholesterol-rich diet for 10 weeks, average atherosclerotic lesion area within aortic roots was significantly decreased
in ApoE / secreted IL-1Ra Tg (47%) and ApoE / intracellular IL-1Ra1 Tg (40%) mice as compared to ApoE / non-Tg
controls. The extent of sudanophilic lesions was reduced within the thoraco-abdominal aorta in ApoE / secreted IL-1Ra (53%) and
ApoE / intracellular IL-1Ra1 (67%) Tg mice. In parallel experiments, we observed early mortality and illness among double deficient
mice, whereas ApoE / IL-1Ra +/+ and ApoE +/+ IL-1Ra / mice were apparently healthy. After 7 weeks of diet, ApoE / IL-1Ra
/ mice exhibited massive aortic inflammation with destruction of the vascular architecture, but no signs of atherosclerosis. ApoE /
IL-1Ra +/+ had atherosclerosis and a moderate inflammatory reaction, whereas ApoE +/+ IL-1Ra / mice were free of vascular lesions.
Macrophages were present in large amounts within inflammatory lesions in the adventitia of ApoE / IL-1Ra / mice.
Conclusion: Our results demonstrate that the IL-1/IL-1Ra ratio plays a critical role in the pathogenic mechanisms leading to vascular
inflammation and atherosclerosis in ApoE / mice.
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Interleukin (IL)-1 is a prototypic pro-inflammatory
cytokine that induces the production of cytokines and
chemokines and increases the expression of adhesion
molecules on endothelial cells, thus leading to the recruit-
ment of inflammatory cells. In addition, IL-1 contributes to
the development of tissue damage by stimulating cell
proliferation and the release of matrix metalloproteases
[1]. IL-1Ra is a natural inhibitor of IL-1 that binds to IL-1
receptors but does not induce any cellular responses. The66 (2005) 583–593d by Elsevier B.V. All rights reserved.
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tory responses and ameliorates the course of different
experimental models of inflammatory diseases [2]. In
addition, administration of recombinant IL-1Ra is approved
in the treatment of rheumatoid arthritis and has recently
been shown to ameliorate other inflammatory diseases as
well [3,4]. Several reports suggest that the balance between
endogenous IL-1 and its antagonist plays a major role in the
modulation of inflammatory responses [5]. Mice lacking IL-
1Ra (IL-1Ra /) are highly susceptible to lipopolysac-
charide-induced lethality [6]. In the collagen-induced
arthritis model, these mice exhibit early arthritis onset and
more severe joint destruction [7]. Moreover, IL-1Ra /
mice develop various type of spontaneous inflammatory
diseases according to their genetic background [8,9].
IL-1Ra is produced as four different isoforms from the
same gene by the use of different first exons, alternative
mRNA splicing, or alternative translation initiation. One
isoform is secreted (sIL-1Ra), whereas the three others lack
a complete leader peptide sequence and remain intracellular
(icIL-1Ra1, 2, 3). The biological role of intracellular
isoforms is still unclear [2].
Atherogenesis is a complex process in which endothe-
lial cell and smooth muscle cell activation appears to play
a central role [10]. Inflammation is now recognized as a
major contributor through effects on lipoprotein metabo-
lism and activation of endothelial cells [11]. Monocytes/
macrophages stand out as playing a particular relevant
role, as demonstrated by the use of mice deficient in
monocyte colony-stimulating factor or neutralizing anti-
bodies against monocyte colony-stimulating factor [12,13].
Important progress has been made in the understanding of
the role of inflammation in atherogenesis by the use of
strains of mice prone to develop atherosclerosis [14].
Knockout mice having targeted inhibition on apolipopro-
tein E (ApoE /) or low density lipoprotein receptor
(LDLR /) genes exhibit massive elevation of circulat-
ing cholesterol levels after cholesterol-rich diet and
develop atherosclerotic lesions throughout the aorta
[15,16]. The pathogenic role of IL-1 was recently
investigated in these two strains of mice. Subcutaneous
administration of recombinant human sIL-1Ra in ApoE
/ mice fed with a cholesterol-rich diet decreased the
size of atherosclerotic lesions [17]. LDLR / mice
crossed with transgenic mice expressing high levels of
murine sIL-1Ra were also partially protected as compared
to their non-transgenic controls. In contrast, LDLR +/+ IL-
1Ra / mice had a tendency to develop foam cell lesions
after a diet rich in cholesterol and cholate [18]. Taken
together, these results indicate that IL-1 contributes to the
mechanisms of atherogenesis in mice. Immunostaining for
IL-1Ra revealed that endothelial cells express IL-1Ra in
mice fed with a cholesterol/cholate-rich diet [18]. How-
ever, the differential expression of IL-1Ra isoforms has not
been investigated and the potential role of endogenous IL-
1Ra in atherogenesis is still unclear.2. Materials and methods
2.1. Mice and genotyping
Transgenic (Tg) mice overexpressing either human sIL-
1Ra or icIL-1Ra1 under the control of a strong and
ubiquitous promoter were bred into a DBA/1 background,
as described [19]. These mice were crossed with ApoE /
mice bred into the C57BL/6J background (Jackson Labo-
ratory, Bar Harbor, ME). Offspring (ApoE +/ IL-1Ra Tg
or non-Tg) were intercrossed to generate ApoE / sIL-
1Ra Tg, ApoE / icIL-1Ra1 Tg, and ApoE / non-Tg
mice of identical mixed background (50% C57BL/6J and
50% DBA/1). In parallel, IL-1Ra / mice (kindly given
by the laboratory of Dr. Hirsch, Department of Biochem-
istry and Molecular Biophysics, Columbia University, New
York, NY) on a DBA/1 background were crossed with
ApoE / mice on a C57BL/6J background. Mice from the
first generation (ApoE +/ IL-1Ra +/) were intercrossed
in order to obtain ApoE / IL-1Ra +/+, ApoE +/+ IL-1Ra
/, and ApoE / IL-1Ra / mice in the same mixed
background (50% C57BL/6J and 50% DBA/1). Genotyping
was performed by PCR analysis of DNA extracted from tail
biopsies, as previously described [6,12,19]. All comparisons
were made to littermate controls of identical mixed genetic
background (50% C57BL/6J and 50% DBA/1). All animal
studies were approved by institutional (University of
Geneva School of Medicine) as well as local veterinary
authorities, and conforms with the Guide for the Care and
Use of Laboratory Animals published by the US National
Institutes of Health.
2.2. Experimental design
Only males were used in the following experiments to
avoid the influence of gender on atherosclerosis. ApoE /
sIL-1Ra Tg mice (n=6), ApoE / icIL-1Ra1 Tg mice
(n=9), and their non-transgenic ApoE / controls (n=6
and n=10, respectively) were used at 10 weeks of age and
fed with a high-cholesterol diet (1.25% cholesterol, 0%
cholate; Research Diets, New Brunswick, NJ) for 10 weeks.
In a separate experiment, 10-week-old ApoE / IL-1Ra
+/+ (n=8), ApoE +/+ IL-1Ra / (n=9), and ApoE /
IL-1Ra / mice (n=6) were fed with a cholesterol-rich
diet for 7 weeks. After diet, mice were sacrificed, blood was
taken, and aortas were subsequently perfused with 0.9%
NaCl. Aortas were separated into 3 parts, of which the roots
and arches were snap-frozen in OCT compound and the
abdominal parts were fixed in 2% paraformaldehyde.
2.3. Analysis of atherosclerotic lesions
The extent of atherosclerosis was assessed in aortic roots
and thoracoabdominal aortas according to standardized
methods [20]. Quantification was performed by computer
image analysis using Zeiss KS400 Software. Briefly, we
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from 6 sections at 50 Am distant from each other by
measuring the area of lipid deposition (stained with Sudan
IV) below the aortic valves. The thoracoabdominal aortas
were stained with Sudan IV and then opened longitudinally
to the iliac bifurcation and pinned out on black wax surface
using 0.2-mm steel pins. The percentage of lipid deposition
was calculated within the total surface area (15 mm from the
iliac bifurcation to the thoracic section of the aorta) using
computer analysis.
The composition of the atherosclerotic lesions was
analysed on cryosections from aortic roots and arches, fixed
in acetone, air-dried, and stained with hematoxylin–eosin or
immunolabeled with an anti-mouse Mac-1 monoclonal
antibody 1:50 (Pharmingen, Heidelberg, Germany). Sec-
tions were incubated with the primary antibody diluted in
PBS supplemented with 10% of the species respective
normal goat serum, followed by the respective biotinylated
secondary antibody and avidin–biotin complex (Vector
Laboratories, Burlingame, CA). The reaction was visualized
by using alkaline phosphatase substrate kit (Vectastain ABC
Systems, Vector Red Substrate kit, Vector Laboratories).
Levamisole solution (Vector Laboratories) was added to the
substrate solution in order to inhibit endogenous alkaline
phosphatase. Sections were then counterstained with May-
er’s hematoxylin solution (Sigma Fluka Chemie AG, Buchs,
Switzerland). In some experiments, macrophages were
identified in sections from aortic roots with a rat monoclonal
anti-CD68 antibody (Serotec, Dusseldorf, Germany) fol-
lowed by FITC goat anti-rat antibodies (Jackson Immunor-
esearch Laboratories, Maine). Sections were then
counterstained with Evans blue (red signal) and with DAPI
(blue nuclear staining). Van-Gieson Miller staining was
performed on 5 Am cryostat sections from aortic roots.
Nuclei were counterstained with Harris hematoxylin sol-
ution (Sigma).
2.4. Determination of plasma levels of total cholesterol,
serum amyloid A (SAA), human IL-1Ra, mouse IL-1b, and
IL-1Ra
Mouse plasma cholesterol concentrations were deter-
mined before and after cholesterol-rich diet in the different
mouse strains, as described elsewhere [21]. The levels of
SAA were determined using a direct ELISA, as previously
described [22]. The plasma concentrations of human IL-1Ra
and mouse IL-1h were measured using commercial Duo Set
ELISA Systems (R&D Systems, Abington, GB). The
circulating concentrations of mouse IL-1Ra were deter-
mined by ELISA, as previously described [23].
2.5. Determination of sIL-1Ra and icIL-1Ra1 mRNA levels
Aortic roots were dissected from 10-week-old wild-type
and ApoE / mice fed with usual diet and ApoE / fed
with cholesterol-rich diet for 10 weeks. Total RNA wasextracted using the TrizolR reagent according to the
manufacturer’s instructions (Invitrogen, Basel, Switzerland),
and quantified by spectrometry.
After DNase I digestion, RNA samples (3 Ag) were
reverse-transcribed using AMV-RT (Promega, Wallisellen,
Switzerland) and random hexamers (Promega). PCR for
sIL-1Ra (40 cycles), icIL-1Ra1 (45 cycles) and h-actin (28
cycles) were performed with primers described in previous
studies [23,24]. Amplifications were carried out under the
following conditions: denaturation for 3 min at 94 8C
followed by cycles of 30 s denaturation at 94 8C, 30 s
annealing at 55 8C and 45 s elongation at 72 8C. PCR
products were visualized by ethidium bromide/2% agarose
gels.
2.6. Statistical analysis
Values are expressed as meanFS.E.M. The Student’s t
test of unpaired observations was used to determine differ-
ences of body weight and total cholesterol levels before and
after diet in the same group, and differences of atheroscler-
otic lesion areas, lipid staining areas, plasma IL-1Ra levels
and SAA levels between the different strains of mice. A
value of Pb0.05 was considered statistically significant.3. Results
3.1. Overexpression of sIL-1Ra or icIL-1Ra1 reduces the
development of atherosclerotic lesions in ApoE / mice
To examine the relative effects of IL-1Ra isoforms on the
development of atherosclerosis, transgenic mice overex-
pressing either human sIL-1Ra or icIL-1Ra1 were crossed
with ApoE / mice. Four different groups were created,
including ApoE / sIL-1Ra Tg mice, ApoE / icIL-
1Ra1 Tg mice, and their respective control ApoE /
littermates. Circulating levels of human IL-1Ra were
elevated in ApoE / sIL-1Ra Tg mice (15.8F3.16 Ag/
mL) and to a lesser extent, in ApoE / icIL-1Ra1 Tg mice
(0.63F0.094 Ag/mL). In contrast, human IL-1Ra was
undetectable in the serum of non-transgenic mice (Table
1). At 10 weeks of age on normal chow diet, the average
weights and total plasma cholesterol levels were not
significantly different in transgenic mice and their respective
littermate controls (Table 1). Atherosclerosis was induced
experimentally by feeding the mice with a cholesterol-rich
diet. The body weight and total plasma cholesterol levels
increased significantly after 10 weeks of diet; however,
there were no significant differences between transgenic
mice and their controls (Table 1).
After 10 weeks of cholesterol-rich diet, the mice were
sacrificed and the extent of atherosclerosis was evaluated.
Aortic root atherosclerotic lesion areas in ApoE / sIL-
1Ra Tg mice (0.159F0.014 mm2) were significantly
decreased by 47% as compared to ApoE / control mice
Table 1
Characteristics of ApoE / sIL-1Ra Tg, ApoE / icIL-1Ra1 Tg, and ApoE / non-Tg mice
ApoE /
(n=6)
ApoE / sIL-1Ra
Tg (n=6)
ApoE /
(n=10)
ApoE / icIL-1Ra1
Tg (n=9)
IL-1Ra (Ag/mL) ND 15.8F3.16 ND 0.63F0.09
Body weight (g)
Before diet 30.83F0.74 27.08F0.92 20.5F0.5 20.94F1.66
After diet 35.48F2T 31.86F1.23T 27.1F1.12T 25.35F0.96T
Total cholesterol (g/L)
Before diet 7.05F0.8 7.7F0.54 5.4F0.4 5.28F0.35
After diet 17.67F1.61T 18.67F1.59T 10.9F0.8T 9.72F0.49T
SAA (Ag/mL) 5.47F2.2 NDy 2.24F0.18 0.18F0.09y
Mice were fed with a cholesterol-rich diet for 10 weeks. Values represent the meanFS.E.M. ND: not detectable, n: number of mice per group. TPb0.05
significantly different before and after diet. yPb0.05, significantly different between transgenic and non-transgenic mice.
F. Merhi-Soussi et al. / Cardiovascular Research 66 (2005) 583–593586(0.3F0.029 mm2) (Figs. 1a and b, 2a). Similarly, aortic root
lesion areas in ApoE / icIL-1Ra1 Tg mice (0.161F0.013
mm2) were significantly reduced by 40% as compared toFig. 1. Representative photographs of atherosclerotic lesions in the aortic roots and thoracoabdominal aortas. ApoE / sIL-1Ra Tg mice (b, f), their littermate
ApoE / controls (a, e), ApoE / icIL-1Ra1 Tg mice (d, h), and their littermate ApoE / controls (c, g), were fed a cholesterol-rich diet for 10 weeks,their littermate controls (0.267F0.028 mm2) (Figs. 1c and d,
2b). Atherosclerotic lesion development was also examined
in preparations of the descending aorta stained with Sudan.
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Fig. 2. Quantitative analysis of atherosclerotic lesion areas in aortic roots and thoracoabdominal aortas. After 10 weeks of cholesterol-rich diet, the extent of
atherosclerotic lesions was analyzed by computer-assisted image quantification within aortic roots (a, b) and thoracoabdominal aortas (c, d). Data represent
mean valuesFS.E.M. of ApoE / sIL-1Ra Tg mice (n=6), their littermate ApoE / controls (n=6) (a and c), ApoE / icIL-1Ra1 Tg mice (n=9), and
their littermate ApoE / controls (n=10) (b and d).
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sudanophilic lipid-rich lesions in abdominal aortas of ApoE
/ sIL-1Ra Tg mice (8.46F1.85 %) or ApoE / icIL-
1Ra1 Tg mice (3.82F1.04%) decreased significantly by
53% and 67% as compared to their littermate control groups
(17.7F3.4% and 11.7F1.83%, respectively). We then
examined the formation of atherosclerotic lesions in aortic
arch sections stained with hematoxylin–eosin. Atheroscler-
otic lesions typically developed at lesion-prone sites, such as
the lesser curvature of the aortic arch and the outflow tracts
of the brachiocephalic, common carotid, and subclavian
arteries. Atherosclerotic lesions at the lesser curvature and
brachiocephalic arteries were less extensive in ApoE /
sIL-1Ra Tg mice (Fig. 3b) as compared to ApoE /
control mice (Fig. 3a). ApoE / icIL-1Ra1 Tg mice (Fig.
3d) had very little signs of plaque formation as compared to
their littermate controls (Fig. 3c).
SAA is an acute-phase protein produced by the liver in
response to pro-inflammatory cytokines, including IL-6 and
IL-1. Plasma levels of SAA were undetectable in the serum
of ApoE / sIL-1Ra Tg mice, whereas detectable levels
were measured in the serum of control ApoE / mice
(5.47F2.2 Ag/mL) (Table 1). Similarly, circulating levels ofSAA were significantly lower in ApoE / icIL-1Ra1 Tg
as compared to ApoE / control mice (0.18F0.09 Ag/mL
versus 2.24F0.18 Ag/mL, Pb0.05) (Table 1).
3.2. IL-1Ra deficiency promotes uncontrolled vascular
inflammation in ApoE / mice
To further test the role of endogenous IL-1Ra and IL-1h
in the pathogenesis of atherosclerosis and vascular inflam-
mation, we first measured the presence of IL-1Ra and IL-1h
in the circulation of ApoE / mice. The levels of both
cytokines remained undetectable before and after choles-
terol-rich diet. As shown in Fig. 4, sIL-1Ra mRNA was
present in all the tissue samples from wild-type and ApoE
/ mice fed with normal chow diet, whereas icIL-1Ra1
mRNAwas only weakly expressed in some of these mice. In
ApoE / mice fed with cholesterol-rich diet for 10 weeks,
sIL-1Ra mRNA levels were elevated and icIL-1Ra1
increased in only two out of four mice.
To examine the role of endogenous IL-1Ra in the
regulation of atherosclerosis, ApoE / mice were crossed
with IL-1Ra / mice to obtain ApoE / IL-1Ra +/+,
ApoE +/+ IL-1Ra /, and ApoE / IL-1Ra / mice.
Fig. 3. Atherosclerotic lesions in the aortic arches. Representative photographs of hematoxylin–eosin stained aortic arch sections from ApoE / sIL-1Ra Tg
mice (b), their littermate ApoE / controls (a), ApoE / icIL-1Ra1 Tg mice (d), and their littermate ApoE / controls (c) fed with cholesterol-rich diet
for 10 weeks (a through d, original magnification 25). LC, lesser curvature; BC, brachiocephalic artery; CCA, common carotid artery; SA, subclavian artery.
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cholesterol levels in ApoE / IL-1Ra +/+ and ApoE /
IL-1Ra / were comparable (5.9F0.6 g/L and
4.88F0.546 g/L, respectively) (Table 2). In contrast, the
levels of plasma cholesterol in ApoE +/+ IL-1Ra / mice
(1.22F0.085 g/L) were significantly lower than in ApoE
deficient mice (Table 2), but in the same range as wild-type1 2 3 4 5 6 7
CT ApoE -/-
MW
Fig. 4. The presence of IL-1Ra mRNA isoforms in aortic roots with and without at
3) and ApoE / mice (lanes 4 to 6) fed with chow diet and ApoE / mice f
prepared and examined by RT-PCR by using specific primers for icIL-1Ra1, sIL
bromide/agarose gel electrophoresis. Total RNA treated without RT (RT, lane 11)
12) were used as negative and positive controls, respectively. MW represents momice (data not shown). At 10 weeks of age, males were fed
with cholesterol-rich diet to induce atherosclerosis.
Whereas, ApoE / IL-1Ra +/+ and ApoE +/+ IL-1Ra
/ mice were apparently healthy, double knockout mice
showed signs of severe illness. The death rate was elevated
in ApoE / IL-1Ra / mice (6/12), and thus all the mice
were sacrificed after 7 weeks of diet. The evolution of bodyicIL-1Ra1
620 bp
sIL-1Ra
520 bp
β-actin
579 bp
8 9 - RT C +
ApoE -/-
with diet
10
herosclerotic lesions. Aortic roots were dissected from wild-type (lanes 1 to
ed for 10 weeks with cholesterol-rich diet (lanes 7 to 10). Total RNA was
-1Ra, and h-actin mRNA. The PCR products were analyzed by ethidium
and thymus total RNA from mice treated with lipopolysaccharide (C+, lane
lecular weight markers.
Table 2
Characteristics of ApoE / and/or IL-1Ra / mice
ApoE /
IL-1Ra +/+
(n=8)
ApoE +/+
IL-1Ra /
(n=9)
ApoE /
IL-1Ra /
(n=6)
Body weight (g)
Before diet 28.7F0.39 19.5F0.559y 17.3F1.045y
After diet 35.7F2.567T 22.9F0.976T,y 19.6F0.33y
Total cholesterol (g/L)
Before diet 5.9F0.6 1.22F0.085y 4.88F0.546
After diet 9.4F0.69T 1.05F0.119y 5.475F0.86y
Mice were fed with a cholesterol-rich diet for 7 weeks. Values represent the
meanFS.E.M., n: number of mice per group. TPb0.05, significantly
different before and after diet. yPb0.05, significantly different from ApoE
/ IL-1Ra +/+ mice.
F. Merhi-Soussi et al. / Cardiovascular Research 66 (2005) 583–593 589weight and plasma cholesterol levels was significantly
different in IL-1Ra deficient mice than in IL-1Ra +/+ mice.
The mean body weight was significantly lower in ApoE +/+Fig. 5. Macroscopic and histological examination of hearts and aortic arches. Apo
fed with cholesterol-rich diet for 7 weeks. Mice were sacrificed and heart and ao
results show representative photographs of heart and aortic arches (a and b), repre
Sudan IV for lipid deposition (original magnification 200) (c and d), and repre
brachiocephalic arteries of aortic arches (original magnification 200) (e and f).IL-1Ra / and ApoE / IL-1Ra / mice than in ApoE
/ IL-1Ra +/+ mice (Table 2). Plasma cholesterol levels
were markedly increased in ApoE / IL-1Ra +/+
(9.4F0.69 g/L), but remained unchanged in ApoE /
IL-1Ra / and ApoE +/+ IL-1Ra / mice (5.475F0.86
g/L and 1.05F0.119 g/L, respectively) (Table 2). The levels
of IL-1h remained below the detection limit of the ELISA in
the three groups of mice.
After 7 weeks of cholesterol-rich diet, we observed the
presence of abundant white tissue surrounding the aortic
arches in double deficient mice (Fig. 5b) but not in ApoE
/ IL-1Ra +/+ (Fig. 5a) and ApoE +/+ IL-1Ra / mice
(data not shown). Staining with Sudan IV revealed the
presence of atherosclerotic lesions in aortic arches of ApoE
/ IL-1Ra +/+ mice (Fig. 5c), whereas ApoE / IL-
1Ra / (Fig. 5d) and ApoE +/+ IL-1Ra / mice (data
not shown) did not develop intimal thickening. Most
interestingly, histological examination of aortic archesE / IL-1Ra +/+ (a, c, e) and ApoE / IL-1Ra / (b, d, f) mice were
rtic arches were taken for macroscopic and histological examination. The
sentative photographs of 5 Am sections of aortic arches stained in red with
sentative photographs of immunostaining for Mac-1 (macrophages) in the
A, adventitia; L, lumen; M, media; NI, neointima.
F. Merhi-Soussi et al. / Cardiovascular Research 66 (2005) 583–593590showed the presence of massive infiltration of inflamma-
tory cells full of lipids and staining positive for macro-
phages in the aortic adventitia of ApoE / IL-1Ra /
mice (Fig. 5d and f). Of note, a milder form of
inflammatory infiltrate in aortic roots was also present in
the adventitia of ApoE / IL-1Ra +/+ mice (Fig. 6a andFig. 6. Histological examination of inflammation in aortic roots and coronary arteri
ApoE / IL-1Ra / (c, f, i, l) mice were fed a cholesterol-rich diet for 7 week
red and elastin areas in purple) shows a complete destruction of elastic lamina and
ApoE / IL-1Ra / mice as compared to aortic valves (a, d) and coronary arte
h). Arrow indicates the elastic lamina and * indicates the destruction of the elastic l
(FITC green signal) in the adventitia of aortic valves of ApoE / IL-1Ra / m
not in ApoE +/+ IL-1Ra / mice (k). Sections are counterstained with Evans blu
(a through c); 100 (d through f and j through l); and 200 (g through i). A, add) but not in ApoE +/+ IL-Ra / mice (Fig. 6b and e).
Van-Gieson Miller stained sections showed that the elastic
lamina within the media of aortic roots and coronary
arteries was destroyed to a large extent in double deficient
mice (Fig. 6c, f, and i), whereas the vascular architecture
was preserved in ApoE / IL-1Ra +/+ (Fig. 6a, d, and g)es. ApoE / IL-1Ra +/+ (a, d, g, j), ApoE +/+ IL-1Ra / (b, e, h, k), and
s. Van-Gieson Miller staining (determination of collagen or fibrotic tissue in
presence of fibrotic tissue in aortic valves (c, f) and coronary arteries (i) of
ries (g) of ApoE / IL-1Ra +/+ and ApoE +/+ IL-1Ra / mice (b, e and
amina. CD68 staining (j, k, and l) shows massive infiltration of macrophages
ice (l) and in the neointima of aortic valves of ApoE / IL-1Ra +/+ (j) but
e (red signal) and DAPI (blue nuclear signal). Original magnifications 25
ventitia; M, media; and NI, neointima.
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Immunostaining with an anti-CD68 antibody was per-
formed to demonstrate the presence of macrophages in
vascular lesions. Histological analysis of aortic roots
demonstrated the presence of CD68-positive cells in the
neointima in ApoE / IL-1Ra +/+ mice (Fig. 6j), whereas
negative staining was observed in ApoE +/+ IL-Ra /
mice (Fig. 6k). In accordance with the findings in aortic
arches, massive macrophage infiltrate was present in
the adventitia and intima of ApoE / IL-1Ra / mice
(Fig. 6l).4. Discussion
In the present study, we showed that overexpression
of either sIL-1Ra or icIL-1Ra1 can inhibit the develop-
ment of atherosclerotic lesions in ApoE / mice. In
addition, we showed that production of sIL-1Ra mRNA
was present in the aortic roots of wild-type and ApoE
/ mice and was further increased with the develop-
ment of atherosclerotic lesions after cholesterol-rich diet.
In contrast, low levels of icIL-1Ra1 mRNA were
mainly present in some ApoE / mice after diet. By
crossing ApoE / mice with IL-1Ra / mice, we
observed that double deficient mice exhibited a severe form
of aortic inflammation with massive infiltration of macro-
phages in the adventitia, lipid accumulation in macro-
phages, and marked destruction of the elastic lamina. ApoE
/ IL-1Ra +/+ developed atherosclerosis, whereas ApoE
+/+ IL-1Ra / had no signs of atherosclerosis or vascular
inflammation. These results indicate that IL-1 plays a
critical role in the pathogenesis of atherosclerosis and
vascular inflammation only in the context of ApoE
deficiency.
IL-1Ra is produced as four different peptides. sIL-1Ra
and icIL-1Ra1 have distinct mRNAs, use different first
exons, and are regulated by specific 5Vupstream promoters
[25]. The icIL-1Ra2 mRNA possesses an additional exon
between icIL-1Ra1 and sIL-1Ra first exons [26]. IcIL-1Ra3
is produced by the use of an alternative translation start site
primarily from sIL-1Ra mRNA [27,28]. Both sIL-1Ra
mRNA and icIL-1Ra1 mRNA are detected in human
atherosclerotic coronary arteries. However, human endothe-
lial cells produced only icIL-1Ra1 upon stimulation with
transforming growth factor-h and lipopolysaccharide/phor-
bol 12-myristate 13-acetate (PMA) [29]. Our results
indicate that sIL-1Ra mRNA is the predominant isoform
in normal and atherosclerotic aortic roots. This finding
suggests that, at least in mice, sIL-1Ra may be more
important than icIL-1Ra1 in the control of atherogenesis.
However, icIL-1Ra3 peptide is also produced from sIL-1Ra
mRNA, and may thus also participate in the regulation of
IL-1 activities.
In ApoE / mice, overexpression of either sIL-1Ra or
icIL-1Ra1 exerts similar protective effects regarding thedevelopment of atherosclerotic lesions. Consistently, we
recently showed that the occurrence of collagen-induced
arthritis is completely prevented in both sIL-1Ra and icIL-
1Ra1 Tg mice [19]. As significant amounts of icIL-1Ra1
are also present in the circulation, we cannot infer from our
data to which extent the protective effect of icIL-1Ra1 is
linked to its secretion, as compared to its intracellular
action.
The results of recent studies as well as our findings
demonstrate that the balance between IL-1 and IL-1Ra is
involved in atherogenesis. ApoE / mice lacking IL-1h
develop less atherosclerotic lesions [30]. In addition, the
role of endogenous IL-1Ra has recently been investigated
by using IL-1Ra +/ mice which have lower circulating
levels of IL-1Ra. ApoE / IL-1Ra +/ mice exhibited
more severe atherosclerotic lesions than ApoE / IL-
1Ra +/+ mice, particularly during early stages of the
disease. Partial IL-1Ra deficiency alters the composition
of atherosclerotic plaques with increased numbers of
macrophages and higher levels of mRNA for MCP-1,
ICAM-1, and VCAM-1 [31]. These findings suggest that
partial IL-1Ra deficiency may be sufficient to promote
atherogenesis in the context of particular genetic disor-
ders associated with hypercholesterolemia. The analysis
of the IL-1Ra gene (IL-1RN) polymorphism in patients
provides an additional support for the role of endogenous
IL-1Ra. The association of the IL-1RN*2 allele, a
polymorphic variant of IL-1RN consisting in two 86-bp
tandem repeats in intron 2, and presence of coronary
artery disease and carotid atherosclerosis in patients has
been recently described [32,33]. Most interestingly,
human umbilical vein endothelial cells isolated from
IL-1RN*2 homozygous individuals produced 2- to 3-fold
less icIL-1Ra1 than cells from subjects with another
more common genotype IL-1RN*1; heterozygous indi-
viduals (IL-1RN*1/*2) producing intermediate levels of
IL-1Ra [29]. This finding provides a potential link
between the results of epidemiological studies and the
role of the IL-1/IL-1Ra balance in atherogenesis in
humans.
The most impressive finding of our study is the
presence of massive vascular inflammation in ApoE /
IL-1Ra / with marked macrophage infiltration in the
adventitia and severe destruction of elastic lamina. These
results suggest that IL-1Ra deficiency is associated with
uncontrolled vascular inflammation in ApoE / mice. The
mice used in these experiments were obtained by crossing
DBA/1 and C57BL/6 mice suggesting a potential role of the
background in our findings. However, during the prepara-
tion of our manuscript, Isoda et al. described the presence of
severe aortic inflammation with identical histological
characteristics in ApoE / IL-1Ra / mice bred into
the C57BL/6 background, thus strongly supporting the role
of IL-1Ra in the regulation of vascular inflammation in
ApoE / mice [31]. As recently demonstrated in mice
partially deficient in IL-1Ra, the recruitment of macro-
F. Merhi-Soussi et al. / Cardiovascular Research 66 (2005) 583–593592phages in vascular lesions is likely to be related to
enhanced expression of several downstream molecules
regulated by IL-1 such as adhesion molecules and
chemokines [31]. Moreover, the occurrence of severe
arteritis mimicking some of the pathologic manifestations
of panarteritis nodosa in IL-1Ra / bred into a mixed
129MF1 background supports a role for IL-1Ra in the
pathophysiology of vasculitis [9]. Interestingly, our data
show that ApoE +/+ IL-1Ra / have no signs of
vascular pathology. This is consistent with previous
results in other mouse backgrounds, including C57BL/6,
BALB/cA and DBA/1, indicating that IL-1Ra deficiency
alone is not sufficient to promote the development of
arteritis.Acknowledgments
We would like to thank Prof. R. Genta (Division of
Clinical Pathology, Department of Pathology–Immunology,
University of Geneva School of Medicine) for useful
discussions and Isabelle Roth, Joan Stalders and Dr. Jean-
Claude Pache for technical help.References
[1] Dinarello CA. Biologic basis for interleukin-1 in disease. Blood
1996;87:2095–147.
[2] Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor
antagonist: role in biology. 27–55.
[3] Gabay C. Cytokine inhibitors in the treatment of rheumatoid arthritis.
Expert Opin Biol Ther 2002;2:135–49.
[4] Hoffman HM, Patel DD. Genomic-based therapy: targeting inter-
leukin-1 for autoinflammatory diseases. Arthritis Rheum 2004;50:
345–9.
[5] Arend WP, Gabay C. Physiologic role of interleukin-1 receptor
antagonist. Arthritis Res 2000;2:245–8.
[6] Hirsch E, Irikura VM, Paul SM, Hirsh D. Functions of interleukin 1
receptor antagonist in gene knockout and overproducing mice. Proc
Natl Acad Sci U S A 1996;93:11008–13.
[7] Ma Y, Thornton S, Boivin GP, Hirsh D, Hirsch R, Hirsch E. Altered
susceptibility to collagen-induced arthritis in transgenic mice with
aberrant expression of interleukin-1 receptor antagonist. Arthritis
Rheum 1998;41:1798–805.
[8] Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al.
Development of chronic inflammatory arthropathy resembling rheu-
matoid arthritis in interleukin 1 receptor antagonist-deficient mice.
J Exp Med 2000;191:313–20.
[9] Nicklin MJ, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial
inflammation in mice lacking the interleukin 1 receptor antagonist
gene. J Exp Med 2000;191:303–12.
[10] Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and
atherosclerosis: new perspectives and therapeutic strategies. Nat Med
2002;8:1249–56.
[11] Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone Jr
MA. Interleukin-1 activation of vascular endothelium. Effects on
procoagulant activity and leukocyte adhesion. Am J Pathol
1985;121:394–403.
[12] Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M.
Decreased atherosclerosis in mice deficient in both macrophagecolony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad
Sci U S A 1995;92:8264–8.
[13] Murayama T, Yokode M, Kataoka H, Imabayashi T, Yoshida H, Sano
H, et al. Intraperitoneal administration of anti-c-fms monoclonal
antibody prevents initial events of atherogenesis but does not reduce
the size of advanced lesions in apolipoprotein E-deficient mice.
Circulation 1999;99:1740–6.
[14] Knowles JW, Maeda N. Genetic modifiers of atherosclerosis in mice.
Arterioscler Thromb Vasc Biol 2000;20:2336–45.
[15] Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft
JG, et al. Severe hypercholesterolemia and atherosclerosis in
apolipoprotein E-deficient mice created by homologous recombina-
tion in ES cells. Cell 1992;71:343–53.
[16] Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK.
Massive xanthomatosis and atherosclerosis in cholesterol-fed low
density lipoprotein receptor-negative mice. J Clin Invest 1994;93:
1885–93.
[17] Elhage R, Maret A, Pieraggi MT, Thiers JC, Arnal JF, Bayard F.
Differential effects of interleukin-1 receptor antagonist and tumor
necrosis factor binding protein on fatty-streak formation in apolipo-
protein E-deficient mice. Circulation 1998;97:242–4.
[18] Devlin CM, Kuriakose G, Hirsch E, Tabas I. Genetic alterations of
IL-1 receptor antagonist in mice affect plasma cholesterol level
and foam cell lesion size. Proc Natl Acad Sci U S A 2002;99:
6280–5.
[19] Palmer G, Talabot-Ayer D, Szalay-Quinodoz L, Maret M, Arend WP,
Gabay C. Mice transgenic for intracellular interleukin-1 receptor
antagonist type 1 are protected from collagen-induced arthritis. Eur J
Immunol 2003;33:434–40.
[20] Tangirala RK, Rubin EM, Palinski W. Quantitation of atherosclerosis
in murine models: correlation between lesions in the aortic origin and
in the entire aorta, and differences in the extent of lesions between
sexes in LDL receptor-deficient and apolipoprotein E-deficient mice.
J Lipid Res 1995;36:2320–8.
[21] James RW, Pometta D. Differences in lipoprotein subfraction
composition and distribution between type I diabetic men and control
subjects. Diabetes 1990;39:1158–64.
[22] Sipe JD, Gonnerman WA, Loose LD, Knapschaefer G, Xie WJ,
Franzblau C. Direct binding enzyme-linked immunosorbent assay
(ELISA) for serum amyloid A (SAA). J Immunol Methods
1989;125:125–35.
[23] Gabay C, Porter B, Fantuzzi G, Arend WP. Mouse IL-1 receptor
antagonist isoforms: complementary DNA cloning and protein
expression of intracellular isoform and tissue distribution of secreted
and intracellular IL-1 receptor antagonist in vivo. J Immunol
1997;159:5905–13.
[24] Palmer G, Guerne PA, Mezin F, Maret M, Guicheux J, Goldring M.B,
et al. Production of interleukin-1 receptor antagonist by human
articular chondrocytes. Arthritis Res 2002;4:226–31.
[25] Jenkins JK, Drong RF, Shuck ME, Bienkowski MJ, Slightom JL,
Arend WP, et al. Intracellular IL-1 receptor antagonist promoter: cell
type-specific and inducible regulatory regions. J Immunol 1997;158:
748–55.
[26] Muzio M, Polentarutti N, Sironi M, Poli G, De Gioia L, Introna
M, et al. Cloning and characterization of a new isoform of the
interleukin 1 receptor antagonist. J Exp Med 1995;182:623–8.
[27] Malyak M, Guthridge JM, Hance KR, Dower SK, Freed JH, Arend
WP. Characterization of a low molecular weight isoform of IL-1
receptor antagonist. J Immunol 1998;161:1997–2003.
[28] Gabay C, Gigley J, Sipe J, Arend WP, Fantuzzi G. Production of IL-1
receptor antagonist by hepatocytes is regulated as an acute-phase
protein in vivo. Eur J Immunol 2001;31:490–9.
[29] Dewberry R, Holden H, Crossman D, Francis S. Interleukin-1 receptor
antagonist expression in human endothelial cells and atherosclerosis.
Arterioscler Thromb Vasc Biol 2000;20:2394–400.
[30] Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, et al.
Lack of interleukin-1beta decreases the severity of atherosclerosis
F. Merhi-Soussi et al. / Cardiovascular Research 66 (2005) 583–593 593in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2003;23:
656–60.
[31] Isoda K, Sawada S, Ishigami N, Matsuki T, Miyazaki K, Kusuhara M,
et al. Lack of interleukin-1 receptor antagonist modulates plaque
composition in apolipoprotein E-deficient mice. Arterioscler Thromb
Vasc Biol 2004;24:1–7.[32] Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, et
al. Interleukin-1 receptor antagonist gene polymorphism and coronary
artery disease. Circulation 1999;99:861–6.
[33] Worrall BB, Azhar S, Nyquist PA, Ackerman RH, Hamm TL,
DeGraba TJ. Interleukin-1 receptor antagonist gene polymorphisms in
carotid atherosclerosis. Stroke 2003;34:790–3.
